Title : VP of Sales & Marketing
Location : Concord, MA
Reporting to : President
About the Company
ITF Therapeutics (ITF) is the U.S.-based rare disease division of Italfarmaco S.p.A., a private multinational group headquartered in Milan, Italy. Established in 1938, its mission has been to improve patient lives and overall well-being through pioneering research & development, high-quality production, and global marketing of branded prescription and non-prescription products.
In January 2024, Italfarmaco launched ITF Therapeutics as a new division in the United States with a focus on the development and commercialization of products to treat rare diseases including Duchenne muscular dystrophy (DMD), a rare and severe form of muscular dystrophy. Highlighting this commitment, ITF Therapeutics successfully secured FDA approval in March 2024 for Givinostat, the first nonsteroidal medication approved to treat all genetic variants of DMD in patients six years of age and older. Givinostat is a histone deacetylase (HDAC) inhibitor that has shown potential in reducing inflammation and fibrosis in muscles, thereby slowing the progression of the disease.
The Role
As a core member of the ITF Leadership Team, the Vice President of Sales & Marketing will drive the commercial strategy and execution for the company’s first product in Duchenne Muscular Dystrophy. This leader will lead a team of passionate professionals and advance the sales and marketing framework to optimize performance and deliver exceptional value to the rare disease community we serve. Anchored in accountability and a relentless commitment to patient impact, this individual will shape brand positioning, elevate customer engagement, and build an enduring commercial foundation.
Primary Responsibilities :
Required Skills :
Vice President Of Marketing • Concord, MA, United States